RNASE1 and Sepsis: ICU patients with SARS-CoV-2 infection (Cohort A), grouped into increasing and decreasing RNase 1 serum levels, were evaluated for various biomarkers and scores (lactate, IL-6, PCT, CRP, sepsis-related organ failure assessment (SOFA) score, and Horowitz score) over a 14-day period.